141 related articles for article (PubMed ID: 11059746)
21. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3.
Kireeva ML; Lam SC; Lau LF
J Biol Chem; 1998 Jan; 273(5):3090-6. PubMed ID: 9446626
[TBL] [Abstract][Full Text] [Related]
22. Heregulin, cysteine rich-61 and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with clinical data.
Sigala F; Georgopoulos S; Papalambros E; Chasiotis D; Vourliotakis G; Niforou A; Kotsinas A; Kavantzas N; Patsouris E; Gorgoulis VG; Bastounis E
Eur J Vasc Endovasc Surg; 2006 Sep; 32(3):238-45. PubMed ID: 16774841
[TBL] [Abstract][Full Text] [Related]
23. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
deFazio A; Chiew YE; Sini RL; Janes PW; Sutherland RL
Int J Cancer; 2000 Aug; 87(4):487-98. PubMed ID: 10918187
[TBL] [Abstract][Full Text] [Related]
24. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ
Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253
[TBL] [Abstract][Full Text] [Related]
25. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
[TBL] [Abstract][Full Text] [Related]
26. CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.
Monnier Y; Farmer P; Bieler G; Imaizumi N; Sengstag T; Alghisi GC; Stehle JC; Ciarloni L; Andrejevic-Blant S; Moeckli R; Mirimanoff RO; Goodman SL; Delorenzi M; Rüegg C
Cancer Res; 2008 Sep; 68(18):7323-31. PubMed ID: 18794119
[TBL] [Abstract][Full Text] [Related]
27. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.
Babic AM; Kireeva ML; Kolesnikova TV; Lau LF
Proc Natl Acad Sci U S A; 1998 May; 95(11):6355-60. PubMed ID: 9600969
[TBL] [Abstract][Full Text] [Related]
28. Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.
Jhabvala-Romero F; Evans A; Guo S; Denton M; Clinton GM
Oncogene; 2003 Nov; 22(50):8178-86. PubMed ID: 14603258
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
[TBL] [Abstract][Full Text] [Related]
30. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium.
Gashaw I; Stiller S; Böing C; Kimmig R; Winterhager E
Endocrinology; 2008 May; 149(5):2261-9. PubMed ID: 18202125
[TBL] [Abstract][Full Text] [Related]
31. Heregulin in breast cancer: old story, new paradigm.
Khurana A; Gonzalez-Guerrico A; Lupu R
Curr Pharm Des; 2014; 20(30):4874-8. PubMed ID: 24283953
[TBL] [Abstract][Full Text] [Related]
32. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.
Tsai MS; Shamon-Taylor LA; Mehmi I; Tang CK; Lupu R
Oncogene; 2003 Feb; 22(5):761-8. PubMed ID: 12569369
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
34. Functional domains of CCN1 (Cyr61) regulate breast cancer progression.
O'Kelly J; Chung A; Lemp N; Chumakova K; Yin D; Wang HJ; Said J; Gui D; Miller CW; Karlan BY; Koeffler HP
Int J Oncol; 2008 Jul; 33(1):59-67. PubMed ID: 18575751
[TBL] [Abstract][Full Text] [Related]
35. The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration.
Jandova J; Beyer TE; Meuillet EJ; Watts GS
Cell Biochem Funct; 2012 Dec; 30(8):687-95. PubMed ID: 22692860
[TBL] [Abstract][Full Text] [Related]
36. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
Schaefer G; Fitzpatrick VD; Sliwkowski MX
Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
[TBL] [Abstract][Full Text] [Related]
37. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R
Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556
[TBL] [Abstract][Full Text] [Related]
38. Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: tissue specificity, inducibility during wound healing, and role of the serum response element.
Latinkic BV; Mo FE; Greenspan JA; Copeland NG; Gilbert DJ; Jenkins NA; Ross SR; Lau LF
Endocrinology; 2001 Jun; 142(6):2549-57. PubMed ID: 11356704
[TBL] [Abstract][Full Text] [Related]
39. Growth factor regulation of a 26S proteasomal subunit in breast cancer.
Barnes CJ; Li F; Talukder AH; Kumar R
Clin Cancer Res; 2005 Apr; 11(8):2868-74. PubMed ID: 15837734
[TBL] [Abstract][Full Text] [Related]
40. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
Barnes CJ; Li F; Mandal M; Yang Z; Sahin AA; Kumar R
Cancer Res; 2002 Mar; 62(5):1251-5. PubMed ID: 11888885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
